ArticleEmerging infectious diseases2018
Emergomyces canadensis, a Dimorphic Fungus Causing Fatal Systemic Human Disease in North America.
Article in Emerging infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.
- Name Changes for Fungi of Medical Importance, 2016-2017.Journal of clinical microbiology · 2019Pooled it
- Long-Read Sequencing and Comparative Genome Analyses of Seven Emergomyces Type-Strains.Mycopathologia · 2026Article
- The Emergence of a Fatal Rash in a Renal Transplant Patient.Open forum infectious diseases · 2026Article
- Emergomyces canadensis: A rare cause of disseminated mycosis in North America.JAAD case reports · 2025Article
- When Emerging Fungal Infections Mimic Tuberculosis: First Reported Case of InvasiveOpen forum infectious diseases · 2025Article
- Dermatologic fungal neglected tropical diseases-Part I. Epidemiology and clinical features.Journal of the American Academy of Dermatology · 2025Review
- Emerging Human Health Problems Caused by Pathogenic and Immuno-activating Fungi.Current topics in microbiology and immunology · 2025Review
- Diagnosis and treatment of a patient with pulmonary infection caused byFuture microbiology · 2024Article
- The pathogenesis of experimental Emergomycosis in mice.PLoS neglected tropical diseases · 2024Article
- Emergomycosis, an Emerging Thermally Dimorphic Fungal Infection: A Systematic Review.Journal of fungi (Basel, Switzerland) · 2023Review
- Emergomycosis in Africa: Time to Pay Attention to This Emerging Deadly Fungal Infection.International journal of general medicine · 2023Review
- Immunologic Diagnosis of Endemic Mycoses.Journal of fungi (Basel, Switzerland) · 2022Review
- Isolated Pulmonary Emergomycosis in an Immunocompetent Patient in Alberta, Canada.Open forum infectious diseases · 2022Article
- CutaneousJAAD case reports · 2021Article
- Epidemiology of fungal diseases in Africa: A review of diagnostic drivers.Current medical mycology · 2021Article
- Emergomycosis, an Emerging Systemic Mycosis in Immunocompromised Patients: Current Trends and Future Prospects.Frontiers in medicine · 2021Review
- Current and New Perspectives in the Diagnosis of Blastomycosis and Histoplasmosis.Journal of fungi (Basel, Switzerland) · 2020Review
- Biosensors and Diagnostics for Fungal Detection.Journal of fungi (Basel, Switzerland) · 2020Review
- Spiromastigoides asexualis: Phylogenetic Analysis and Evaluation as a Cause of False-PositiveJournal of clinical microbiology · 2020Article
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report 4 patients in North America with disease caused by Emergomyces canadensis, a newly proposed species of pathogenic dimorphic fungus. Affected persons were immunocompromised; lived in Saskatchewan, Colorado, and New Mexico; and had systemic disease involving blood, skin, cervix, lung, and lymph node. Two cases were fatal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.